Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2024-04-04 Regulatory Filings
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on a merger agreement and regulatory review updates related to that merger, including a Second Request from the FTC. There are no financial statements or detailed financial performance data included. The document is not an annual or quarterly report, nor is it an earnings release or audit report. It is an announcement of a significant corporate event (merger update) filed as a regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2024-04-04 English
Director's Dealing 2024
Director's Dealing
2024-04-02 English
Director's Dealing 2024
Director's Dealing
2024-04-02 English
Regulatory Filings 2024
Regulatory Filings
2024-04-01 English
Regulatory Filings 2024
Regulatory Filings
2024-04-01 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a proxy statement or related materials filed with the SEC. It is titled 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934' and is marked as 'Definitive Additional Materials.' The content and metadata indicate it is related to proxy solicitation and shareholder voting information. The document length is short (1140 characters), consistent with additional proxy materials rather than a full report. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI).
2024-03-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.